文献速递腹部技术与安全USMR

超声与动态对比增强简化MRI的检查质量及其对早期肝细胞癌检出影响

Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection.
PubMed 文献 · Abdom Radiol (NY) · 2024-11-15

多中心病例对照研究纳入216例早期肝细胞癌病例与432例无肝癌对照,对比肝脏超声与动态对比增强简化MRI(DCE-AMRI)的检查质量对早期肝细胞癌检出率的影响,严重质量受限在超声与DCE-AMRI中分别占7%与8%。严重受限时超声敏感度从79.6%降至21.7%、DCE-AMRI从86.1%降至50.0%;超声严重受限者中DCE-AMRI检出早期肝癌的比值比显著高于超声(OR 8.23 [1.25-54.02])。

要点

  • 超声严重受限时对早期肝癌敏感度仅21.7%,DCE-AMRI为50.0%,均明显下降。
  • 肥胖(OR 2.08)与MASLD(OR 1.98)与超声严重受限相关,但与DCE-AMRI严重受限无关。
  • 超声严重受限者中DCE-AMRI检出早期肝癌的比值比显著高于超声(OR 8.23 [1.25-54.02])。

核心结论

  • 对于因肥胖和MASLD导致超声严重受限的患者,DCE-AMRI可能更适于检出早期肝细胞癌;两种方法对失代偿期肝硬化患者均受限,可能需要替代策略。

研究设计与样本

  • 多中心病例对照研究,纳入216例符合米兰标准的早期肝细胞癌病例与432例无肝癌对照,均为肝硬化患者,且在2012-2019年间6个月内接受肝脏超声与动态对比增强简化MRI(DCE-AMRI)检查;由两名放射科医师独立、盲法判读两种检查并评估检查质量。

诊断标准与关键数值

  • 检查质量评为无/轻度、中度或严重受限;与无/轻度受限相比,严重受限时超声检出早期肝癌敏感度79.6% vs. 21.7%(P < 0.001),DCE-AMRI敏感度86.1% vs. 50.0%(P = 0.001)。

临床应用与阅片要点

  • 超声严重受限时DCE-AMRI检出早期肝癌的比值比显著高于超声(OR 8.23 [1.25-54.02]);肥胖与MASLD与超声严重受限相关(OR 2.08, 95%CI [1.32-3.32];OR 1.98 [1.12-3.44]),但与DCE-AMRI严重受限无关;失代偿期肝硬化(Child-Pugh C)与两种检查严重受限均相关(超声OR 2.54 [1.37-4.58],DCE-AMRI OR 3.96 [2.36-6.58])。

局限性

  • 作者指出两种方法对失代偿期肝硬化患者均受限,可能需要替代策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: MRI is a potential alternative to ultrasound for hepatocellular carcinoma (HCC) detection. We evaluated the impact of ultrasound and dynamic abbreviated MRI (AMRI) exam quality on early-stage HCC detection.

METHODS: We conducted a multicenter case-control study among patients with cirrhosis (cases with early-stage HCC per Milan Criteria; controls without HCC) who underwent both a liver ultrasound and dynamic contrast-enhanced (DCE) AMRI within 6 months in 2012-2019. Two radiologists performed independent, blinded interpretations of both exams for HCC detection and scored exam quality as no/mild, moderate, or severe limitations. Associations between exam quality, patient characteristics, and HCC detection were assessed by odds ratios (OR).

RESULTS: Of 216 cases and 432 controls, severe limitations were reported in 7% and 8% of ultrasounds and DCE-AMRIs, respectively. Severe limitations at ultrasound were associated with obesity (OR 2.08, 95%CI [1.32-3.32]) and metabolic dysfunction-associated steatotic liver disease (MASLD) (OR 1.98 [1.12-3.44]) but not for DCE-AMRI. Decompensated cirrhosis (Child-Pugh C) was associated with severe limitations for both ultrasound (OR 2.54 [1.37-4.58]) and DCE-AMRI (OR 3.96 [2.36-6.58]). Compared to exams with no/mild limitations, exams with severe limitations had lower sensitivity for ultrasound (79.6% vs. 21.7%, P < 0.001) and AMRI (86.1% vs. 50.0%, P = 0.001). In patients in whom ultrasound was severely limited, DCE-AMRI had significantly higher odds of early-stage HCC detection than ultrasound (OR 8.23 [1.25-54.02]).

CONCLUSIONS: HCC detection by DCE-AMRI may be preferred in patients with severe limitations at ultrasound due to obesity and MASLD. Both modalities remain limited for patients with decompensated cirrhosis, for whom alternative strategies may be needed.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Seif El Dahan K, Yokoo T, Mendiratta-Lala M, et al. Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection. Abdom Radiol (NY). 2024. PMID: 39542949. doi:10.1007/s00261-024-04674-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。